Classification using fractional anisotropy predicts conversion in genetic frontotemporal dementia, a proof of concept.
Rogier A FeisJeroen van der GrondMark J R J BoutsJessica L PanmanJackie M PoosTijn M SchoutenFrank de VosLize C JiskootElise G P DopperMark A van BuchemJohn C van SwietenSerge A R B RomboutsPublished in: Brain communications (2020)
Frontotemporal dementia is a highly heritable and devastating neurodegenerative disease. About 10-20% of all frontotemporal dementia is caused by known pathogenic mutations, but a reliable tool to predict clinical conversion in mutation carriers is lacking. In this retrospective proof-of-concept case-control study, we investigate whether MRI-based and cognition-based classifiers can predict which mutation carriers from genetic frontotemporal dementia families will develop symptoms ('convert') within 4 years. From genetic frontotemporal dementia families, we included 42 presymptomatic frontotemporal dementia mutation carriers. We acquired anatomical, diffusion-weighted imaging, and resting-state functional MRI, as well as neuropsychological data. After 4 years, seven mutation carriers had converted to frontotemporal dementia ('converters'), while 35 had not ('non-converters'). We trained regularized logistic regression models on baseline MRI and cognitive data to predict conversion to frontotemporal dementia within 4 years, and quantified prediction performance using area under the receiver operating characteristic curves. The prediction model based on fractional anisotropy, with highest contribution of the forceps minor, predicted conversion to frontotemporal dementia beyond chance level (0.81 area under the curve, family-wise error corrected P = 0.025 versus chance level). Other MRI-based and cognitive features did not outperform chance level. Even in a small sample, fractional anisotropy predicted conversion in presymptomatic frontotemporal dementia mutation carriers beyond chance level. After validation in larger data sets, conversion prediction in genetic frontotemporal dementia may facilitate early recruitment into clinical trials.
Keyphrases
- diffusion weighted imaging
- contrast enhanced
- magnetic resonance imaging
- resting state
- genome wide
- clinical trial
- electronic health record
- functional connectivity
- copy number
- big data
- computed tomography
- magnetic resonance
- mild cognitive impairment
- gene expression
- cross sectional
- randomized controlled trial
- deep learning
- dna methylation
- data analysis
- physical activity
- open label
- double blind
- phase ii